iwNHL 2020 Session V
T-cell Therapies for Lymphoma
Presentations
CD19-CAR-T cells
Jeremy Abramson, MD, Massachusetts General Hospital Cancer Center, Boston, MA
12 September, 2020
CD30, CD5 and/or 7 CAR-T cells
Cath Bollard, MBChB, MD, FRACP, FRCPA, Children's National Health System, Washington, DC
12 September, 2020
T cell-engaging therapies – BiTEs and beyond
Stephen Gottschalk, MD, St. Jude Children's Research Hospital, Memphis, TN
12 September, 2020
